All Articles

Elounda Hills' record sales reveal more than a hot property market; they signal Crete's transformation into a global hub, powered by new infrastructure and a new vision for luxury.

Star Therapeutics' innovative drug VGA039 lands a $2B deal with Incyte, signaling a major shift in treating the most common inherited bleeding disorder.

Canada's flag carrier rolls out a patriotic summer campaign, but operational headwinds, airport chaos, and labor unease threaten a smooth landing.

A new report reveals AI engines now favor drugstore science over luxury prestige, signaling a tectonic shift in how brands are built and valued.

HCW Biologics executes a reverse stock split to avoid Nasdaq delisting. Is it a necessary survival tactic or a warning sign for investors? We analyze.

After years as a national embarrassment, 24 Sussex Drive is getting a lifeline. The plan is more than a renovation; it’s a strategic pivot to private funding.

Medicenna Therapeutics is advancing its promising cancer immunotherapies, MDNA11 and MDNA113, while navigating a tight financial runway. Can it deliver?

Maalexi just closed a $2.8M round led by Saudi's top insurer to build a regulated crypto exchange for crops. Is this the future of global food security?

FactSet's new AI tool promises to democratize portfolio analytics. But in a high-stakes industry, can it deliver powerful insights without sacrificing trust?

Lupin's generic approval for Xtandi isn't just about price. Its new single-pill dose could transform patient care and challenge Astellas's market dominance.

reAlpha Mortgage is ditching traditional commissions for a flat-fee model with stock options and AI. A bold commercialization play in the war for loan officers.

Asia's largest home furnishing firm just launched an AI that designs entire homes in 30 minutes, linking plans directly to its massive robot factories.

New research reveals that even with pensions, government workers need more. Financial guidance, digital tools, and literacy are key to true confidence.

CDT Equity's bet on SarborgQ signals a new era where quantum computing and AI accelerate drug formulation, creating a high-stakes race for intellectual property.

A small biotech's dual-front war on cancer reveals a powerful new playbook: leveraging elite partnerships to pioneer a preventative vaccine and a novel CAR-T.

A new customs deal with Uruguay isn't just stopping smugglers. It's a key move to secure supply chains, de-risk a $317M trade route, and pave the way for a larger FTA with South America's MERCOSUR bloc.

After a tumultuous delisting from Nasdaq, Luna Innovations finds a new home with TJC, trading public market woes for private equity's deep pockets.

As clients demand simplicity, Clever, GLGR, and The Right Now merge to form Punch Group, betting that an integrated model is the future of marketing.

With its new Museum of Exploration, National Geographic is gambling that high-tech immersion and a premium price tag can capture a new generation of explorers.

A new partnership between Remote and isolved embeds global hiring into a major US HR platform, turning international expansion from a legal maze into a simple click.